Private Label Peptide Eyelash Serum Manufacturer Low MOQ

The minimum order quantity for a private label peptide eyelash serum depends almost entirely on whether you are working with a stock formula or commissioning a custom formula. Stock formulas — where the manufacturer already has a validated base containing peptides like Biotinoyl Tripeptide-1 or Myristoyl Pentapeptide-17 — routinely accept MOQs of 100 to 300 units. That low threshold exists because no R&D cost is being amortized; the lab is simply filling existing batches under your label. Semi-custom routes, where a cosmetic chemist modifies an existing base to adjust peptide concentration, pH, or fragrance, typically push the MOQ to 300–500 units. The lab needs to run a new stability batch and challenge test on the modified formula, which requires enough units to cover those testing costs. Fully custom formulations — where you are specifying a proprietary peptide stack, a novel film-forming system, or clinical-level active concentrations — almost always require 500 to 2,000 units as a starting run. Below that, the cost-per-unit economics become prohibitive because raw material procurement, filling line changeovers, and quality-control sampling are fixed expenses regardless of batch size. Geography also matters. US and Canadian manufacturers tend to have slightly higher MOQs (200+ for stock) because of higher labor and compliance overhead. South Korean manufacturers, who dominate the peptide serum OEM market, often accept 100-unit MOQs on stock formulas but may require 1,000+ for custom, and lead times can be longer due to shipping. The most common mistake first-time founders make is negotiating MOQ in isolation without accounting for packaging. A manufacturer may accept 150 units of formula, but the precision-tip applicator tube supplier has a 500-unit MOQ — leaving you to either buy excess packaging or negotiate a packaging-inclusive quote. Always lock in MOQ for formula AND packaging in the same conversation. If you are in early validation mode, AJ Cosmo Labs is a useful tool: you can post a brief specifying your target MOQ and receive responses only from manufacturers whose minimums match, so you are not spending weeks chasing labs that can't serve your volume.

Cost for a private label peptide eyelash serum is built from four distinct buckets: formula cost, packaging cost, regulatory and testing costs, and setup or tooling fees. Understanding each bucket prevents sticker shock when you receive your first quote. Formula cost per unit (ex-packaging) typically runs $4–$9 for a stock peptide serum at 100–300 units, $7–$14 for a semi-custom formula at 300–500 units, and $10–$22 or more for a fully custom formula at 500–2,000 units. The largest single variable inside formula cost is the peptide raw material itself. High-purity Myristoyl Pentapeptide-17 and Acetyl Tetrapeptide-3 from reputable suppliers (e.g., Lipotec/Lubrizol, Lucas Meyer) carry significant price premiums over generic Chinese-sourced alternatives. A manufacturer using premium peptide inputs at clinically relevant percentages will quote higher than one using trace amounts of a lower-purity grade — and the difference in consumer results is real. Packaging cost at low MOQ is often the bigger shock. A precision-tip applicator bottle (2–5 mL) in low quantities (100–500 units) costs $1.50–$4.50 per unit depending on material (PET vs. glass), cap type, and whether UV coating or custom printing is included. Custom-printed boxes add $0.80–$2.50 per unit at low volumes. Total landed packaging cost at 200 units could easily exceed your formula cost. One-time setup costs include regulatory fees (safety assessor sign-off for EU products: $500–$2,000; MoCRA facility registration: free but the admin work has a cost), stability testing if the stock formula has not already been tested ($800–$2,500 for accelerated stability), and tooling for custom packaging molds (can run $1,500–$8,000 for a bespoke tube mold). A realistic all-in landed cost for a 200-unit MOQ stock peptide eyelash serum with printed packaging, properly tested and compliant, is $12–$22 per unit. A 1,000-unit custom run with premium peptides might land at $18–$30 per unit all-in before you apply your retail markup. The common mistake is budgeting only for formula cost and being blindsided by packaging and compliance spend. Use AJ Cosmo Labs to collect itemized quotes that break out each cost bucket — it makes apples-to-apples comparison far easier across multiple manufacturers.

Lead time for a private label peptide eyelash serum breaks into four sequential stages, and understanding each one helps you set realistic launch timelines and avoid the number-one founder mistake: launching a marketing campaign before the product exists. Stage 1 — Formula selection and brief approval (1–2 weeks). Whether you are selecting a stock formula or submitting a custom brief, the manufacturer needs to review your requirements, confirm raw material availability, and issue a formal quote and contract. Peptide raw materials can have their own lead times; some specialty actives from European suppliers carry 4–6 week procurement windows if not in stock. Stage 2 — Formula development or adaptation and stability initiation (2–8 weeks). For stock formulas this stage is minimal — the cosmetic chemist may only need to confirm batch records and initiate a small pilot fill. For semi-custom or fully custom work, this is where most time is spent: the chemist formulates, adjusts, and initiates accelerated stability testing (typically a 4-week minimum accelerated run at 40 °C / 75% RH, though full 12-week data is the standard for a launch-ready product). Stage 3 — Pre-production sample, review, and approval (1–2 weeks). You receive 3–10 units of the finished, packaged product for your approval. This is where you assess texture, applicator flow, packaging quality, and label accuracy. Revision cycles here can add 1–2 weeks if changes are needed. Stage 4 — Full production run and QC release (1–4 weeks). The batch is manufactured, undergoes in-process and finished-goods QC, and is released for shipment. Batch size affects this: 150-unit runs on a small filling line may be done in a day; 2,000-unit runs on a scheduled commercial line may require a 2–3 week slot. Total realistic timelines: 3–6 weeks for stock formula with existing packaging; 8–12 weeks for semi-custom; 12–20 weeks for fully custom with new packaging tooling. South Korean OEM manufacturers add 2–4 weeks of ocean freight on top. The most common mistake is assuming a manufacturer's quoted lead time starts the day you pay the deposit. It actually starts after the formula brief is finalized, raw materials are procured, and a production slot is assigned. Clarify this explicitly before signing. AJ Cosmo Labs lets you filter by lead time in the app so you only engage manufacturers who can meet your launch window.

A high-quality peptide eyelash serum contains at least one, and ideally two to three, signal or carrier peptides supported by a sensible accessory ingredient stack. The peptide selection signals whether a manufacturer is using evidence-backed actives at functional concentrations or simply adding trace amounts for marketing purposes. Biotinoyl Tripeptide-1 (INCI: Biotinoyl Tripeptide-1) is the most widely studied lash peptide. It is a biotin-conjugated tripeptide that strengthens the follicle-dermal papilla connection, which is critical for reducing lash loss. Functional use levels are typically 0.0005%–0.002%. Brands license this as Procapil (Sederma) or similar commercial complexes. Myristoyl Pentapeptide-17 promotes keratin synthesis in the cortex of the lash shaft, contributing to thicker, denser-appearing lashes. It is often paired with Myristoyl Hexapeptide-16 in commercial actives like Lash Booster (Lipotec). Typical inclusion: 0.001%–0.003%. Acetyl Tetrapeptide-3 targets anchoring proteins in the follicle basement membrane. It is commonly included in commercial ingredient complexes specifically marketed for lash and brow care. Use level: 0.001%–0.005%. Most premium serums also include supportive actives: Panthenol (Pro-Vitamin B5) at 0.5%–2% for conditioning, biotin (as a standalone cosmetic additive), Camellia sinensis extract as an antioxidant protecting the sensitive periocular tissue, and Sodium Hyaluronate to maintain hydration along the lash line. The carrier system matters as much as the actives. A well-formulated serum uses a light, fast-absorbing gel base (hydroxyethylcellulose or carbomer at low concentration) with a pH of 6.5–7.0 to match the periocular tissue. Preservatives must be chosen carefully for eye-area use — phenoxyethanol is acceptable at ≤0.5–1% (EU caps it lower for eye-area); some formulators prefer a multi-component system (e.g., ethylhexylglycerin + phenoxyethanol) at even lower levels. Ask your cosmetic chemist or manufacturer to disclose the peptide concentration range on a spec sheet — not just the INCI name. If they refuse, treat it as a red flag. Reputable manufacturers on AJ Cosmo Labs provide full transparency on active concentrations upon request under NDA.

No FDA pre-market approval is required to sell a peptide eyelash serum in the United States, provided the product is formulated and marketed as a cosmetic. Cosmetics do not require FDA approval before going to market under the Federal Food, Drug, and Cosmetic Act. However, this does not mean anything goes — the regulatory requirements are meaningful and recently expanded. Under the Modernization of Cosmetics Regulation Act (MoCRA), signed into law in December 2022, all cosmetic manufacturers and certain brand owners (called 'responsible persons') must register their facilities with the FDA and submit product listings that include the product name, intended use, and full INCI ingredient list. Facility registration and product listing were required by December 29, 2023 for large companies and July 1, 2024 for small businesses. Confirm that any US manufacturer you work with is MoCRA-registered; this is now a baseline compliance requirement. MoCRA also requires cosmetic companies to report serious adverse events (SAEs) to the FDA within 15 business days. Your contract manufacturer should advise you on building a complaint-handling and adverse event reporting process before you launch. The critical line is the cosmetic/drug distinction. A peptide serum that claims to 'visibly enhance lash appearance' or 'condition lashes' is a cosmetic. A product that claims to 'grow new lashes,' 'treat lash loss,' or contains bimatoprost (a prescription prostaglandin analogue used in Latisse) is a drug. Drug claims on a cosmetically marketed product expose you to FDA warning letters, import alerts, and product seizure. Review every marketing claim — including influencer and social media posts — against this line. For California sales, Prop 65 requires a warning if your product contains listed chemicals at levels above safe harbor thresholds. Some fragrance components and preservatives trigger Prop 65 — have your formulator review the INCI list. If you plan to sell in the EU simultaneously, note that you will need a separate Product Information File (PIF), a Cosmetic Product Safety Report (CPSR) signed by a qualified EU safety assessor, and a Responsible Person (RP) entity based in the EU or UK. AJ Cosmo Labs connects you with regulatory consultants who can advise on dual-market compliance alongside manufacturer sourcing.

Yes, you can sell a private label peptide eyelash serum in the EU, but the regulatory pathway requires more pre-market preparation than the US cosmetic route. EU Cosmetics Regulation 1223/2009 governs all cosmetics sold in the European Union, Norway, Iceland, and Liechtenstein, and it operates on a mandatory pre-market compliance model — not the post-market notification model the US uses. The core requirements are: (1) A Responsible Person (RP) — a legal entity established in the EU — who takes formal responsibility for the product's compliance. If you are a non-EU brand, you need to appoint an EU-based RP, typically a regulatory affairs consultancy or a distribution partner who accepts this role in writing. Post-Brexit UK brands need a separate UK RP for UK sales. (2) A Product Information File (PIF) maintained and accessible to EU authorities. The PIF includes the full formula (quantitative and qualitative), manufacturing process description, safety data for each ingredient, stability data, and the Cosmetic Product Safety Report. (3) A Cosmetic Product Safety Report (CPSR), Part A and Part B, signed by a qualified Responsible Person for Safety — typically a toxicologist or pharmacist with the EU-required credentials. CPSR preparation costs €500–€2,000 depending on the complexity of the formula. (4) Notification through the EU Cosmetic Products Notification Portal (CPNP) before placing the product on the market. This is free but requires an EU RP login. For a peptide eyelash serum specifically, the safety assessor will scrutinize preservative levels (phenoxyethanol is restricted to ≤1% and some EU guidance suggests lower for eye-area products), check any restricted fragrance allergens under the updated Annex III (the 2023 fragrance allergen amendments), and confirm no Annex II-prohibited ingredients are present. The most common mistake for first-time EU entrants is assuming their US-compliant INCI list is automatically EU-compliant. It is not: some US-permitted preservative systems are restricted in the EU, and the labeling requirements (including mandatory allergen declaration at ≥0.01% for leave-on products, language requirements per member state, and the product function statement) differ materially. Timeline: allow 6–12 weeks to complete CPSR, appoint an RP, and notify on CPNP before your EU launch date. AJ Cosmo Labs can connect you with regulatory consultants experienced in EU cosmetic compliance alongside your manufacturer search.

Finding a reputable manufacturer for a private label peptide eyelash serum at low MOQ is genuinely harder than it sounds, because most directories mix unvetted suppliers with legitimate GMP-certified labs, and the manufacturers best suited to low-MOQ work are often not actively marketing at trade shows where volume brands shop. Start by defining your requirements before you search: target MOQ (be specific — 150 units? 300?), formula type (stock or custom), packaging format (precision-tip tube, wand applicator, dropper), regulatory market (US only, EU, both), and timeline. Manufacturers will qualify you out quickly if you cannot answer these questions — which is actually a good sign, because it means they are serious labs with real constraints. Vetting criteria to apply to every candidate: (1) ISO 22716 or equivalent GMP certification — ask for a current certificate with expiry date. (2) Reference products they have manufactured in the eye-area serum category — not just general skincare. Periocular formulation requires additional sensitivity expertise. (3) Stability and challenge test data for any stock formula you are considering — do not accept verbal reassurances. (4) Sample policy — any legitimate lab will provide pre-production samples. (5) Clear IP and NDA terms — for custom formulas, confirm formula ownership in writing before development begins. (6) MoCRA registration status if manufacturing in or for the US market. Sources for finding manufacturers include industry trade shows (Cosmoprof, Beauty World Middle East, In-Cosmetics), ingredient supplier referrals (your peptide supplier — e.g., Lubrizol, Givaudan — often has a list of labs that purchase their actives), and vetted B2B platforms. Cold-emailing general directories produces a high volume of unvetted responses and wastes significant time. AJ Cosmo Labs is purpose-built for exactly this search. The iOS app lets you post a structured formula brief — including your MOQ, peptide active targets, regulatory market, and packaging requirements — and receive responses only from manufacturers that have been admin-reviewed before being listed on the platform. You can filter by MOQ, browse manufacturer profiles, message suppliers directly, and track sample requests all in one place. Download AJ Cosmo Labs from the App Store, post your brief in under ten minutes, and let vetted cosmetic labs come to you instead of the other way around.